All Stories

  1. The Dilemma of Choice: Options for Nonoperable Hepatocellular Carcinoma Management

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2025, Elsevier

    Dr Michael Lock

  2. Comparison of CellSearch versus Parsortix circulating tumor cell enumeration and molecular characterization: A pilot study in metastatic prostate cancer patients

    Article • Next Research, June 2025, Elsevier

    Dr Michael Lock

  3. Prognostic Index for Liver Radiation (PILiR)

    Article • Current Oncology, September 2024, MDPI AG

    Dr Michael Lock

  4. Prognostic Index for Liver Radiation (PILiR)

    Article • August 2024, MDPI AG

    Dr Michael Lock

  5. The Current Role of Radiation in the Management of Cholangiocarcinoma—A Narrative Review

    Article • Cancers, May 2024, MDPI AG

    Dr Michael Lock

  6. Stereotactic Body Radiation Therapy (SBRT) Versus Transarterial Chemoembolization (TACE) for Treatment Of Hepatocellular Carcinoma: a Meta-Analysis of Propensity Matched Studies

    Article • University of Toronto Medical Journal, January 2024, University of Toronto Libraries - UOTL

    Dr Michael Lock

  7. Are Radiation Target Volumes for Postmastectomy Radiation Therapy Too Large? Initial Report of the Complication Avoidance of Reconstruction Implant Radiation Therapy (CARIT) Study

    Article • Current Oncology, February 2023, MDPI AG

    Dr Michael Lock

  8. Radiotherapy and radiosensitization in breast cancer: Molecular targets and clinical applications

    Article • Critical Reviews in Oncology/Hematology, January 2022, Elsevier

    Dr Michael Lock

  9. Intrafraction motion monitoring to determine PTV margins in early stage breast cancer patients receiving neoadjuvant partial breast SABR

    Article • Radiotherapy and Oncology, May 2021, Elsevier

    Dr Michael Lock

  10. Cost Minimization Analysis of Hypofractionated Radiotherapy

    Article • Current Oncology, January 2021, MDPI AG

    Dr Michael Lock

  11. A Phase I/II Trial of Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy for High-Risk Prostate Cancer (FASTR-2): Preliminary Results and Toxicity Analysis

    Article • Advances in Radiation Oncology, October 2019, Elsevier

    Dr Michael Lock

  12. Radiobiologically Guided Radiation Therapy in Large Primary and Metastatic Hepatic Lesions

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2018, Elsevier

    Dr Michael Lock

  13. Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer

    Article • Breast Cancer Research and Treatment, August 2018, Springer Science + Business Media

    Dr Michael Lock

  14. Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer

    Article • JAMA Oncology, June 2018, American Medical Association (AMA)

    Dr Michael Lock

  15. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies

    Article • Technology in Cancer Research & Treatment, January 2018, SAGE Publications

    Dr Michael Lock

  16. The Utility of Penile Bulb Contouring to Localise the Prostate Apex as Compared to Urethrography

    Article • Journal of Medical Imaging and Radiation Sciences, November 2017, Elsevier

    Dr Michael Lock

  17. Lessons Learned From the Two-Step QA Process in NRG Oncology/RTOG 1005, A Phase 3 Trial for Early-Stage Breast Cancer

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2017, Elsevier

    Dr Michael Lock

  18. Advances in external beam stereotactic body radiotherapy: principle concerns in implementing a liver radiation program

    Article • Chinese Clinical Oncology, September 2017, AME Publishing Company

    Dr Michael Lock

  19. Reducing Patient Waiting Times for Radiation Therapy and Improving the Treatment Planning Process: a Discrete-event Simulation Model (Radiation Treatment Planning)

    Article • Clinical Oncology, June 2017, Elsevier

    Dr. Mehmet A. Begen, Dr Michael Lock

  20. Potential benefit of rotational radiation therapy

    Article • Future Oncology, April 2017, Future Medicine

    Dr Slav Yartsev, Dr Michael Lock

  21. A multivariable model to predict survival for patients with hepatic carcinoma or liver metastasis receiving radiotherapy

    Article • Future Oncology, January 2017, Future Medicine

    Dr Michael Lock, Dr Slav Yartsev

  22. Strategies to tackle the challenges of external beam radiotherapy for liver tumors

    Article • World Journal of Hepatology, January 2017, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Michael Lock

  23. Computed tomography imaging assessment of postexternal beam radiation changes of the liver

    Article • Future Oncology, December 2016, Future Medicine

    Dr Michael Lock

  24. Postediting prostate magnetic resonance imaging segmentation consistency and operator time using manual and computer-assisted segmentation: multiobserver study

    Article • Journal of Medical Imaging, November 2016, SPIE

    Dr Michael Lock

  25. Predicting which patients actually receive radiation following breast conserving therapy in Canadian populations

    Article • Canadian Journal of Surgery, October 2016, Canadian Medical Association (CMA)

    Dr Michael Lock

  26. 92: Identification of Patients that will not Benefit from Hepatic Radiation

    Article • Radiotherapy and Oncology, September 2016, Elsevier

    Dr Michael Lock

  27. Sci‐Fri AM: MRI and Diagnostic Imaging ‐ 03: The influence of sampling percentage in deformable registration on kinetic model analysis results in DCE‐MRI of the breast

    Article • Medical Physics, August 2016, Wiley

    Dr Michael Lock

  28. Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directions

    Article • Expert Review of Anticancer Therapy, April 2016, Informa Healthcare

    Dr Michael Lock

  29. A Single Institution Consensus on the Use of Sequential or Concurrent Hormonal Therapy for Breast Cancer Patients Receiving Radiation Therapy

    Article • Cureus, April 2016, Cureus, Inc.

    Dr Michael Lock

  30. Evaluation of Health Economics in Radiation Oncology: A Systematic Review

    Article • International Journal of Radiation Oncology*Biology*Physics, April 2016, Elsevier

    Dr Michael Lock

  31. A phase II trial to evaluate single-dose stereotactic body radiation therapy (SBRT) prior to surgery for early-stage breast carcinoma: SIGNAL (stereotactic image-guided neoadjuvant ablative radiation then lumpectomy) trial

    Article • Journal of Radiation Oncology, November 2015, Springer Science + Business Media

    Dr Michael Lock

  32. A Systematic Review of Health Economic Evaluations in Radiation Oncology

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2015, Elsevier

    Dr Michael Lock

  33. Concurrent or Sequential Hormonal and Radiation Therapy in Breast Cancer: A Literature Review.

    Article • Cureus, October 2015, Cureus, Inc.

    Dr Michael Lock

  34. Abscopal Effects: Case Report and Emerging Opportunities

    Article • Cureus, October 2015, Cureus, Inc.

    Dr Michael Lock

  35. How has SBRT progressed in different countries and what this can teach us in the future

    Article • Future Oncology, October 2015, Future Medicine

    Dr Michael Lock, Dr Eric L Chang

  36. The significance of circulating tumor cells in prostate cancer patients undergoing adjuvant or salvage radiation therapy

    Article • Prostate Cancer and Prostatic Diseases, August 2015, Nature

    Dr Michael Lock

  37. A Phase 1/2 Trial of Brief Androgen Suppression and Stereotactic Radiation Therapy (FASTR) for High-Risk Prostate Cancer

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2015, Elsevier

    Dr Michael Lock

  38. Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma

    Article • Future Oncology, November 2014, Future Medicine

    Dr Michael Lock

  39. In Regard to Parikh et al

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2014, Elsevier

    Dr Michael Lock

  40. Dosimetric Comparison of Volumetric Modulated Arc Therapy, Tomotherapy, and Intensity Modulated Radiation Therapy for Radiation Dose Escalation of Hepatic Malignancies

    Article • International Journal of Radiation Oncology*Biology*Physics, September 2014, Elsevier

    Dr Michael Lock

  41. Identification of Patients With Liver Cancer That Will Not Benefit From Radiation

    Article • International Journal of Radiation Oncology*Biology*Physics, September 2014, Elsevier

    Dr Michael Lock

  42. Dynamic contrast enhanced CT aiding gross tumor volume delineation of liver tumors: An interobserver variability study

    Article • Radiotherapy and Oncology, April 2014, Elsevier

    Dr Michael Lock

  43. Phase 1 Study of Image-Guided and Radiobiologically-Guided Stereotactic Body Radiation Therapy for Hepatic Lesions

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2013, Elsevier

    Dr Michael Lock

  44. Improving the Efficiency of Radiation Therapy Delivery by Resource Optimization

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2012, Elsevier

    Dr Michael Lock, Dr. Mehmet A. Begen

  45. Radiotherapy for Liver Metastases: A Review of Evidence

    Article • International Journal of Radiation Oncology*Biology*Physics, March 2012, Elsevier

    Dr Michael Lock

  46. The Impact of Post-Mastectomy Radiation Therapy on Male Breast Cancer Patients—A Case Series

    Article • International Journal of Radiation Oncology*Biology*Physics, February 2012, Elsevier

    Dr Michael Lock

  47. Circulating tumour cells in prostate cancer patients receiving salvage radiotherapy

    Article • Revista de Oncología, February 2012, Springer Science + Business Media

    Dr Michael Lock

  48. A Phase II Trial of Arc-Based Hypofractionated Intensity-Modulated Radiotherapy in Localized Prostate Cancer

    Article • International Journal of Radiation Oncology*Biology*Physics, August 2011, Elsevier

    Dr Michael Lock

  49. Phase I Trial of Simultaneous In-Field Boost With Helical Tomotherapy for Patients With One to Three Brain Metastases

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2011, Elsevier

    Dr Michael Lock

  50. Brachytherapy with permanent gold grain seeds for squamous cell carcinoma of the lip

    Article • Radiotherapy and Oncology, March 2011, Elsevier

    Dr Michael Lock

  51. Technology assessment of automated atlas based segmentation in prostate bed contouring

    Article • Radiation Oncology, January 2011, Springer Science + Business Media

    Dr Michael Lock

  52. Radiation recall dermatitis due to gemcitabine does not suggest the need to discontinue chemotherapy

    Article • Oncology Letters, October 2010, Spandidos Publications

    Dr Michael Lock

  53. Systematic review of dose–volume parameters in the prediction of esophagitis in thoracic radiotherapy

    Article • Radiotherapy and Oncology, June 2009, Elsevier

    Dr Michael Lock

  54. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer

    Article • Cytometry Part B Clinical Cytometry, August 2008, Wiley

    Dr Michael Lock

  55. Gabapentin for the treatment of menopausal hot flashes

    Article • Menopause, March 2008, Wolters Kluwer Health

    Dr Michael Lock

  56. Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer

    Article • Radiation Oncology, January 2008, Springer Science + Business Media

    Dr Michael Lock, Dr Slav Yartsev

  57. Correlation of Clinically Significant Radiation Esophagitis With Dose-Volume Histogram Parameters in Lung Cancer

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2007, Elsevier

    Dr Michael Lock

  58. A Prospective Evaluation of Helical Tomotherapy

    Article • International Journal of Radiation Oncology*Biology*Physics, June 2007, Elsevier

    Dr Michael Lock

  59. Minimal decrease in hot flashes desired by postmenopausal women in family practice

    Article • Menopause, March 2007, Wolters Kluwer Health

    Dr Michael Lock

  60. 2840

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2006, Elsevier

    Dr Michael Lock

  61. 2322

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2006, Elsevier

    Dr Michael Lock

  62. 2327

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2006, Elsevier

    Dr Michael Lock

  63. A comparison of prostate IMRT and helical tomotherapy class solutions

    Article • Radiotherapy and Oncology, September 2006, Elsevier

    Dr Michael Lock, Dr Slav Yartsev

  64. 23 An NTCP formalism accounting for complications from radiation treatment and tumour invasion

    Article • Radiotherapy and Oncology, September 2006, Elsevier

    Dr Michael Lock

  65. Prostate contouring uncertainty in megavoltage computed tomography images acquired with a helical tomotherapy unit during image-guided radiation therapy

    Article • International Journal of Radiation Oncology*Biology*Physics, June 2006, Elsevier

    Dr Michael Lock

  66. 22 Development find Psychometric Properties of the Prostate Cancer Radiation Toxicity Questionnaire

    Article • Radiotherapy and Oncology, September 2005, Elsevier

    Dr Michael Lock

  67. Consolidative abdominopelvic radiotherapy after surgery and carboplatin/paclitaxel chemotherapy for epithelial ovarian cancer

    Article • International Journal of Radiation Oncology*Biology*Physics, May 2005, Elsevier

    Dr Michael Lock

  68. Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies

    Article • International Journal of Radiation Oncology*Biology*Physics, March 2005, Elsevier

    Dr Michael Lock

  69. Prediction of radiation pneumonitis by dose–volume histogram parameters in lung cancer—a systematic review

    Article • Radiotherapy and Oncology, May 2004, Elsevier

    Dr Michael Lock